| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
|
28,254 |
1,755 |
$3.58M |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
31,406 |
1,346 |
$3.02M |
| J1270 |
Injection, doxercalciferol, 1 mcg |
15,138 |
906 |
$1.35M |
| A4657 |
Syringe, with or without needle, each |
3,299 |
1,198 |
$638K |
| J1756 |
Injection, iron sucrose, 1 mg |
4,713 |
802 |
$365K |
| 82728 |
|
1,501 |
912 |
$177K |
| 83540 |
|
1,497 |
910 |
$175K |
| 83550 |
|
1,498 |
911 |
$174K |
| 85041 |
|
1,511 |
903 |
$158K |
| 85048 |
|
1,509 |
900 |
$157K |
| 83970 |
|
990 |
600 |
$93K |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
308 |
88 |
$25K |
| 82306 |
|
276 |
161 |
$22K |
| 82947 |
|
18 |
12 |
$0.00 |